GlassScriptPhysician profile
Mohammad N Al Shroof
NPI 1578519286
$22,486.73
in general payments reported to CMS, 2019-2025
82 companies · $3,240 in 2025
The $3,240 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,283 · 2020: $2,790 · 2021: $3,330 · 2022: $3,159 · 2023: $3,252 · 2024: $3,433 · 2025: $3,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,821 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,821.46 |
| Education | $102.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,983.19 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,599.11 | 2019-2025 | Farxiga, Airsupra, Pulmicort |
| Abbvie INC. | $1,578.75 | 2020-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $1,267.27 | 2019-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $1,266.96 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $1,190.98 | 2019-2025 | Rexulti |
| Astellas Pharma US INC | $1,133.08 | 2019-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $993.86 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $986.24 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $955.61 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $910.70 | 2019-2025 | Xarelto, Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $439.53 | 2019-2025 | Jardiance, Synjardy |
| Amarin Pharma, INC. | $413.98 | 2019-2021 | |
| Eisai INC. | $402.66 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $402.44 | 2019-2025 | Verquvo, Belsomra, Gardasil 9 |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $388.39 | 2021-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $388.04 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $373.77 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $372.04 | 2021-2025 | |
| Allergan, INC. | $288.99 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $288.67 | 2019-2022 | |
| Noven Therapeutics, LLC | $266.32 | 2023-2025 | Xelstrym |
| Supernus Pharmaceuticals, INC. | $241.91 | 2019-2022 | Tlando, Xyosted |
| Teva Pharmaceuticals USA, INC. | $206.60 | 2019-2025 | Austedo, Austedo Xr, Ajovy |
| Indivior INC. | $195.55 | 2019-2025 | Sublocade |
| Paratek Pharmaceuticals, INC. | $189.04 | 2021-2025 | Nuzyra |
| Biohaven Pharmaceutical Holding Company LTD. | $162.33 | 2022 | |
| Vanda Pharmaceuticals INC. | $159.56 | 2023-2025 | Fanapt, Hetlioz |
| Ironwood Pharmaceuticals, INC | $159.15 | 2019-2022 | |
| Exact Sciences Corporation | $152.87 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $151.59 | 2023-2025 | Gemtesa |
| Lundbeck LLC | $150.84 | 2020-2025 | Rexulti |
| Esperion Therapeutics, INC. | $147.59 | 2020-2025 | Nexletol |
| Beta Bionics, INC. | $138.53 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Horizon Therapeutics Plc | $135.36 | 2019-2023 | Krystexxa |
| Xeris Pharmaceuticals, INC. | $130.95 | 2022-2025 | Gvoke Hypopen, Keveyis |
| Ardelyx, INC. | $124.45 | 2024-2025 | Ibsrela |
| Collegium Pharmaceutical, INC. | $120.87 | 2019-2025 | Belbuca |
| Antares Pharma, INC. | $119.32 | 2019-2022 | |
| Shield Therapeutics INC | $118.87 | 2023-2025 | Accrufer |
| Dexcom, INC. | $117.72 | 2021-2024 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $115.96 | 2022-2025 | Caplyta |
| Abbott Laboratories | $112.98 | 2021-2025 | Freestyle Libre |
| Takeda Pharmaceuticals U.S.A., INC. | $108.71 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $99.06 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $84.38 | 2019-2025 | Zoryve |
| Portola Pharmaceuticals, LLC | $72.80 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $66.96 | 2023 | Ztlido |
| Biogen, INC. | $63.03 | 2019-2024 | |
| Nestle Healthcare Nutrition INC. | $54.22 | 2021-2022 | |
| Braeburn INC. | $53.76 | 2025 | Brixadi |
| Arbor Pharmaceuticals, INC. | $53.29 | 2019-2021 | |
| Medtronic Minimed, INC. | $49.01 | 2020 | |
| Abiomed | $45.45 | 2023 | Impella |
| Idorsia Pharmaceuticals US INC | $44.80 | 2022-2023 | Quviviq |
| Tolmar, INC. | $43.31 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $42.69 | 2019-2020 | |
| Nevro Corp. | $42.32 | 2021 | |
| Medtronic, INC. | $39.53 | 2021-2022 | |
| Radius Health, INC. | $39.52 | 2021 | |
| Phathom Pharmaceuticals, INC. | $38.25 | 2024 | Voquezna |
| Upsher-Smith Laboratories LLC | $31.35 | 2019-2021 | |
| Grifols USA, LLC | $29.12 | 2019 | |
| Melinta Therapeutics, LLC | $26.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $26.69 | 2021-2022 | |
| Senseonics, Incorporated | $25.00 | 2019-2020 | |
| Halozyme INC | $23.00 | 2023 | |
| Ucb, INC. | $21.67 | 2023 | Nayzilam |
| Clarus Therapeutics INC. | $21.56 | 2021 | |
| Avanir Pharmaceuticals, INC. | $21.40 | 2019 | |
| Smith+Nephew, INC. | $20.70 | 2024 | Collagenase Santyl |
| Pacira Therapeutics, INC. | $19.32 | 2019 | |
| Viatris Specialty LLC | $19.30 | 2025 | Yupelri |
| Cequr Corporation | $16.52 | 2025 | Cequr Simplicity |
| Currax Pharmaceuticals LLC | $16.20 | 2024 | Contrave |
| Hikma Pharmaceuticals USA | $13.11 | 2020 | |
| Impel Pharmaceuticals INC. | $12.78 | 2023 | Trudhesa |
| Dermira, INC. | $11.99 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.89 | 2019 | |
| Daiichi Sankyo INC. | $11.60 | 2019 | |
| Endo Pharmaceuticals INC. | $11.58 | 2020 | |
| Orexo US, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
Rexulti $925Nurtec Odt $663Farxiga $516Veozah $439Ilet Bionic Pancreas $416Rybelsus $413Ozempic $409Xifaxan $366Repatha $363Mounjaro $358Zavzpret $346Otezla $321Ubrelvy $315Trelegy Ellipta $294Verquvo $287Xarelto $280Eliquis $272Xelstrym $266Wegovy $247Trulance $219Kerendia $213Korlym $200Leqembi $197Qulipta $192Airsupra $187Vraylar $180Linzess $171Jardiance $170Comirnaty $170Zepbound $159Cologuard Collection Kit $153Gemtesa $152Ilet Insulin Infusion Kit Contact Detach $139Ilet Insulin Infusion Kit Inset $139Paxlovid $131Ibsrela $124Accrufer $119Belbuca $108Abrysvo $102Prevnar 20 $102Fanapt $101Creon $96.84Shingrix $88.68Evenity $88.01Nuzyra $87.50Arexvy $83.50Sublocade $82.22Myrbetriq $77.99Entresto $74.63Leqvio $74.63Prolia $73.20Belsomra $69.45Krystexxa $69.23Caplyta $68.62Ztlido $66.96Dexcom G6 Transmitter $64.38Gvoke Hypopen $61.16Hetlioz $58.18Freestyle Libre $55.05Brixadi $53.76Impella $45.45Jatenzo $43.31Gardasil 9 $42.42Capvaxive $42.42Austedo $41.90Viberzi $39.28Voquezna $38.25Synjardy $37.30Austedo Xr $36.19Quviviq $32.89Steglatro $31.98Emgality $29.32Tzield $23.04Xyosted $23.00Tlando $23.00Nayzilam $21.67Keveyis $21.49Collagenase Santyl $20.70Spravato $20.30Yupelri $19.30Tepezza $18.03Nexletol $17.04Cequr Simplicity $16.52Pulmicort $16.47Contrave $16.20Oxbryta $15.73Ajovy $14.94Zoryve $14.61Cibinqo $13.89Eucrisa $13.89Trudhesa $12.78Breztri $10.35
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Al Shroof listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.